GLP-1 Sema refers to semaglutide, a synthetic peptide analog of human glucagon-like peptide-1 (GLP-1). Semaglutide has a modified peptide structure and is characterized by its interaction with the GLP-1 receptor.
The compound shares approximately 94% sequence homology with human GLP-1 and incorporates structural modifications that distinguish it from the naturally occurring peptide. These characteristics make semaglutide a well-defined reference compound for controlled laboratory investigations involving peptide characterization, GLP-1 receptor interactions, molecular signaling, and related biochemical pathways.
This GLP-1 Sema product is supplied as research material for controlled laboratory and analytical applications.